6704

Novel Method for Identifying Personalized Anti-Cancer Drug Combinations

Willner Itamar, HUJI, Faculty of Science, The Institute of Chemistry
Kotler Moshe, HUJI, School of Medicine - IMRIC, Immunology and Cancer Research
Pikarsky Eli, HUJI, School of Medicine - IMRIC, Immunology and Cancer Research
Nechushtai Rachel, HUJI, Faculty of Science, The Alexander Silberman Institute for Life Sciences

A novel and personalized method for identifying the optimal anti-cancer treatment, through simultaneous detection of unique tumor sensitivities to multiple drugs or drug combinations in a multiplex manner, (this can be done) in vitro on cancer cells, on cancer biopsies or in vivo in the patient's body.

Contact for more information:

Mel Larrosa
VP Business Development Healthcare
+972-2-6586692